The focus will be on biopharmaceuticals, rare diseases, vaccines and animal health. The China-based operation will employ 1,400 people, said Frank Jiang, Sanofi’s head of R&D in Asia-Pacific.

CAS news release, Oct. 17, 2014

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny